The Safety and Efficacy of Olverembatinib as Maintenance Therapy or Preemptive Therapy After Allo-HSCT in Adult Ph + Acute Lymphoblastic Leukemia
Latest Information Update: 30 Oct 2024
At a glance
- Drugs Olverembatinib (Primary) ; Triazoles
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 30 Oct 2024 New trial record